Skip to main content
Log in

Cytoplasmic localization of programmed cell death 4 contributes to its anti-apoptotic function

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

We have demonstrated that the loss of programmed cell death 4 (Pdcd4), a translation inhibitor, induces apoptosis; however, when, where, and how Pdcd4 decreases in response to apoptotic stimuli and, conversely, exerts the anti-apoptotic function within normal cells are incompletely understood. Endogenous Pdcd4 was present in both the cytoplasm and nucleus of cells that survived. In cells that had committed to die by apoptotic stimuli, cytoplasmic Pdcd4 was lost more slowly than was nuclear Pdcd4; eventually, Pdcd4 remaining in the cytoplasm was lost and then apoptotic events were induced. Treatment with leptomycin B led to blocked nuclear export of Pdcd4 in cells exposed to apoptotic stimuli, assuming its translocation from the nucleus to the cytoplasm in the early phase of apoptotic processes. In cells overexpressing Pdcd4, the protein localized exclusively cytoplasmic. Overexpression of Pdcd4 resulted in reduced incidence of apoptosis in cells exposed to apoptotic stimuli compared to control cells. In addition, the expression of Procaspase-3, which is translated from the mRNA targeted by Pdcd4, was suppressed in cells overexpressing Pdcd4. Thus, the localization of Pdcd4 to the cytoplasm may be responsible for the suppression of the target mRNA translation and apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Steller H (1995) Mechanisms and genes of cellular suicide. Science 267:1445–1449

    Article  CAS  Google Scholar 

  2. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462

    Article  CAS  Google Scholar 

  3. Strasser A, Harris AW, Bath ML, Cory S (1990) Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331–333

    Article  CAS  Google Scholar 

  4. McDonnell TJ, Korsmeyer SJ (1991) Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349:254–256

    Article  CAS  Google Scholar 

  5. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW (1991) Enforced BCL2 expression in B lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88:8661–8665

    Article  CAS  Google Scholar 

  6. Watanabe-Fukunaga R, Brannan CL, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314–317

    Article  CAS  Google Scholar 

  7. Barr PJ, Tomei LD (1994) Apoptosis and its role in human disease. Biotechnology 12:487–493

    Article  CAS  Google Scholar 

  8. Strasser A, O’Connor L, Dixit VM (2000) Apoptosis signaling. Annu Rev Biochem 69:217–245

    Article  CAS  Google Scholar 

  9. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Eamshaw WC (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346–347

    Article  CAS  Google Scholar 

  10. Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjo T (1995) Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166:297–301

    Article  CAS  Google Scholar 

  11. Onishi Y, Hashimoto S, Kizaki H (1998) Cloning of the TIS gene suppressed by topoisomerase inhibitors. Gene 215:453–459

    Article  CAS  Google Scholar 

  12. Azzoni L, Zatsepina O, Abebe B, Bennett IM, Kanakaraj P, Perussia B (1998) Differential transcriptional regulation of CD161 and a novel gene, 199/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J Immunol 161:3493–3500

    CAS  PubMed  Google Scholar 

  13. Matsuhashi S, Yoshinaga H, Yatsuki H, Tsugita A, Hori K (1997) Isolation of a novel gene from a human cell line with Pr-28mAb which recognizes a nuclear antigen involved in the cell cycle. Res Commun Biochem Cell Mol Biol 1:109–120

    CAS  Google Scholar 

  14. Göke A, Göke R, Knolle A, Trusheim H, Schmidt H, Wilmen A, Carmody R, Göke B, Chen YH (2002) DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. Biochem Biophys Res Commun 297:78–82

    Article  Google Scholar 

  15. Lankat-Buttgereit B, Göke R (2009) The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 101:309–317

    Article  CAS  Google Scholar 

  16. Allgayer H (2010) Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 73:185–191

    Article  Google Scholar 

  17. Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, Colburn NH (2003) The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23:26–37

    Article  Google Scholar 

  18. Liwak U, Thakor N, Jordan LE, Roy R, Lewis SM, Pardo OE, Seckl M, Holcik M (2012) Tumor suppressor PDCD4 represses internal ribosome entry site-mediated translation of antiapoptotic proteins and is regulated by S6 kinase 2. Mol Cell Biol 32:1818–1829

    Article  CAS  Google Scholar 

  19. Onishi Y, Kizaki H (1996) Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. Biochem Biophys Res Commun 228:7–13

    Article  CAS  Google Scholar 

  20. Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH (2004) Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 23:8135–8145

    Article  CAS  Google Scholar 

  21. Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC, Tan TH, Colburn NH (2006) Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26:1297–1306

    Article  Google Scholar 

  22. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K, Matsuhashi S (2006) Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25:6101–6112

    Article  CAS  Google Scholar 

  23. Young MR, Santhanam AN, Yoshikawa N, Colburn NH (2010) Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue? Mol Interv 10:76–79

    Article  CAS  Google Scholar 

  24. Davis BN, Hiyard AC, Lagna G, Hata A (2008) Smad proteins control DROSHA-mediated microRNA maturation. Nature 454:56–61

    Article  CAS  Google Scholar 

  25. Eto K, Goto S, Nakashima W, Ura Y, Abe S (2012) Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA. Cell Death Differ 19:573–581

    Article  CAS  Google Scholar 

  26. Nishi K, Yoshida M, Fujiwara D, Nishikawa M, Horinouchi S, Beppu T (1994) Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J Biol Chem 269:6320–6324

    CAS  PubMed  Google Scholar 

  27. Fornerod M, Ohno M, Yoshida M, Mattaj IW (1997) CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051–1060

    Article  CAS  Google Scholar 

  28. Fukuda M, Asano S, Nakamura T, Adachi M, Yoshida M, Yanagida M, Nishida E (1997) CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390:308–311

    Article  CAS  Google Scholar 

  29. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M (2006) S6K1- and βTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314:467–471

    Article  CAS  Google Scholar 

  30. Böhm M, Sawicka K, Siebrasse JP, Brehmer-Fastnacht A, Peters R, Klempnauer KH (2003) The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene 22:4905–4910

    Article  Google Scholar 

  31. Matsuhashi S, Narisawa Y, Ozaki I, Mizuta T (2007) Expression patterns of programmed cell death 4 protein in normal human skin and some representative skin lesions. Exp Dermatol 16:179–184

    Article  CAS  Google Scholar 

  32. Singh P, Wedeken L, Waters LC, Carr MD, Klempnauer KH (2011) Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation. Oncogene 30:4864–4873

    Article  CAS  Google Scholar 

  33. Rosner M, Hengstschläger M (2011) Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR. Oncogene 30:4509–4522

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr. M. Pagano (School of Medicine, New York University, New York, U.S.A.) for providing us with the expression constructs encoding the Pdcd4 wild type and mutant, and Professor emerita M. A. DiBerardino for editorial review of the manuscript. This work was supported by Grants-in-Aid for Scientific Research (Grant Number: 26460276 and 15H00898) from the Ministry of Education, Science, Sports, and Culture of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ko Eto.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takaki, S., Eto, K. Cytoplasmic localization of programmed cell death 4 contributes to its anti-apoptotic function. Mol Cell Biochem 448, 155–164 (2018). https://doi.org/10.1007/s11010-018-3322-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-018-3322-z

Keywords

Navigation